Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eleventy
Tel Aviv, Tel Aviv District, Israeleleventymilano.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Eleven Therapeutics develops next-generation RNA therapeutics using synthetic chemistry and artificial intelligence. Their proprietary platforms enable high-throughput mapping of structure–activity relationships for optimized mRNA and xRNA molecules. The company’s pipeline focuses on extended-release mRNA therapies addressing metabolic, hematologic, infectious, and respiratory diseases. No clinical results have been published yet; the company remains preclinical with strong venture backing and strategic partnerships.
- Therapeutic areas
- PulmonologyInfectious DiseasesMetabolic DisordersHematology
- Modalities
- mRNA-based drugsRNA therapy
- Industry
- Biotech
02
Partnerships
Novo Nordisk – research collaboration to discover cell-specific carriers of nucleic acid therapeuticsBill & Melinda Gates Foundation – funding/support partner
Beyond the preview
Go deeper on Eleventy.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eleventy.